- Companies in the index
- 144
Venture capital firm investing in enterprise software and healthcare.
Read the US Venture Partners profileCagent Vascular is listed as a current portfolio company of US Venture Partners on US Venture Partners' own portfolio page.
Cagent Vascular pioneers Serration Remodeling Therapy (SRT) creating controlled lines of weakness to release the internal elastic lamina, reducing recoil and increasing luminal gain in PAD angioplasty.
Source: cagentvascular.com, read November 2026
Cagent Vascular is a Healthcare company. Its owner on record, US Venture Partners, is a firm. US Venture Partners lists 144 companies in the index, 9 of them in Healthcare.
Venture capital firm investing in enterprise software and healthcare.
Read the US Venture Partners profileCagent Vascular is listed as a current portfolio company of US Venture Partners on US Venture Partners' own portfolio page.
Cagent Vascular is in Healthcare. Classified from the company's own description.
US Venture Partners lists 8 other Healthcare companies in the index, including AImbient, Carlsmed, Carrot, HighLife Medical and Luminopia.
Cagent Vascular's website is https://cagentvascular.com/.
6 of 143 shown
See the full US Venture Partners portfolio.
Browse PE-backed companies.